Publications by authors named "Jim Lordan"

Claim this Profile
A
A European multi-center, randomized controlled trial of Pirfenidone in bronchiolitis obliterans syndrome after bilateral lung transplantation.
Michael Perch, Paul Corris, Jim Lordan, Vasiliki Bessa, Jesper Magnusson

Eur Respir J· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pulmonary Hypertension: Intensification and Personalization of Combination Rx (PHoenix): A phase IV randomized trial for the evaluation of dose-response and clinical efficacy of riociguat and selexipag using implanted technologies.
Frances Varian, Jennifer Dick, Christian Battersby, Stefan Roman, Jenna Ablott, Jim Lordan

Pulm Circ· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship between inflammatory status and microbial composition in severe asthma and during exacerbation.
Sarah Diver, Koirobi Haldar, Pamela Jane McDowell, John Busby, Vijay Mistry, Jim Lordan

Allergy· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Biological heterogeneity in idiopathic pulmonary arterial hypertension identified through unsupervised transcriptomic profiling of whole blood.
Sokratis Kariotis, Emmanuel Jammeh, Emilia M Swietlik, Josephine A Pickworth, Christopher J Rhodes, Jim Lordan

Nat Commun· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biological heterogeneity in idiopathic pulmonary arterial hypertension identified through unsupervised transcriptomic profiling of whole blood.
Sokratis Kariotis, Emmanuel Jammeh, Emilia M Swietlik, Josephine A Pickworth, Christopher J Rhodes, Jim Lordan

Nat Commun· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishing expert consensus for the optimal approach to holistic risk-management in pulmonary arterial hypertension: a Delphi process and narrative review.
Colin Church, Wendy Gin-Sing, Duncan Grady, Martin Johnson, David G Kiely, Jim Lordan

Expert Rev Respir Med· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Positioning imatinib for pulmonary arterial hypertension: A phase I/II design comprising dose finding and single-arm efficacy.
Martin R Wilkins, Mikel A Mckie, Martin Law, Andreas A Roussakis, Lars Harbaum, Jim Lordan

Pulm Circ· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perioperative Management of Pulmonary Hypertension. a Review.
Christopher Wood, Mindaugas Balciunas, Jim Lordan, Adrian Mellor

J Crit Care Med (Targu Mures)· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bayesian Inference Associates Rare Variants with Specific Phenotypes in Pulmonary Arterial Hypertension.
Emilia M Swietlik, Daniel Greene, Na Zhu, Karyn Megy, Marcella Cogliano, Jim Lordan

Circ Genom Precis Med· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EXPRESS: Statement on imaging and pulmonary hypertension from the Pulmonary Vascular Research Institute (PVRI).
David G Kiely, David Levin, Paul Hassoun, David D Ivy, Pei-Ni Jone, Jim Lordan

Pulm Circ· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo T-depleted reduced-intensity transplantation for -related immune dysfunction.
Eleni Tholouli, Katherine Sturgess, Rachel E Dickinson, Andrew Gennery, Andrew J Cant, Jim Lordan

Blood· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful outcome following pneumonectomy in a teenage boy with cystic fibrosis: a case report.
Zheyi Liew, Santosh Mallikarjuna, Asif Hasan, F Kate Gould, Su Bunn, Jim L Lordan

BMC Pulm Med· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bile acid aspiration in people with cystic fibrosis before and after lung transplantation.
Malcolm Brodlie, Ali Aseeri, Jim L Lordan, Andrew G N Robertson, Michael C McKean

Eur Respir J· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A combination of two novel alpha globin variants Hb Bridlington (HBA1) and Hb Taybe (HBA2) resulting in severe hemolysis, pulmonary hypertension, and death.
Quentin A Hill, Lisa Farrar, Jim Lordan, Alice Gallienne, Shirley Henderson

Hematology· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanistic differences between phenotypes of chronic lung allograft dysfunction after lung transplantation.
Monika I Suwara, Bart M Vanaudenaerde, Stijn E Verleden, Robin Vos, Nicola J Green, Jim Lordan

Transpl Int· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of single lung transplant with and without the use of cardiopulmonary bypass.
Clare Burdett, Tanveer Butt, Jim Lordan, John H Dark, Stephen C Clark

Interact Cardiovasc Thorac Surg· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bile acids are present in the lower airways of people with cystic fibrosis.
Ali Aseeri, Malcolm Brodlie, Jim Lordan, Paul Corris, Jeff Pearson

Am J Respir Crit Care Med· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The human syndrome of dendritic cell, monocyte, B and NK lymphoid deficiency.
Venetia Bigley, Muzlifah Haniffa, Sergei Doulatov, Xiao-Nong Wang, Rachel Dickinson, Jim Lordan

J Exp Med· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pseudomonas aeruginosa colonization of the allograft after lung transplantation and the risk of bronchiolitis obliterans syndrome.
Phil Botha, Lynda Archer, Rachel L Anderson, Jim Lordan, John H Dark

Transplantation· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The phosphodiesterase type IV inhibitor cilomilast decreases pro-inflammatory cytokine production from primary bronchial epithelial cells in lung transplantation patients.
Des M Murphy, Chris Ward, Ian A Forrest, Gail Pritchard, Debbie Jones, Jim L Lordan

J Heart Lung Transplant· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis